COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04448704
Recruitment Status : Recruiting
First Posted : June 26, 2020
Last Update Posted : June 30, 2020
Information provided by (Responsible Party):
Yale-NUS College

Brief Summary:
This study aims to understand the mental health of migrant workers diagnosed with COVID-19 or quarantined in dormitories during the COVID-19 pandemic.

Condition or disease
Mental Health Issue

Detailed Description:

Worldwide, there are an estimated 164 million migrant workers. Although studies have documented how workers have an increased risk of adverse health outcomes, little is known about their vulnerability during a health crisis.

In the current COVID-19 outbreak, nearly 30,000 migrant workers have been infected with SARS-CoV-2 in Singapore. This represents 9 in 10 of the local cases, and 25 dormitories have been gazetted to contain the spread of the virus. Correspondingly, these measures have placed a spotlight on the well-being of migrant workers.

In this research protocol, the investigators propose to administer a survey to understand the mental health of migrant workers: (1) diagnosed with COVID-19 (housed in NUS or Expo), and (2) quarantined in dormitories. This will allow the investigators to capture the base rate of depression, anxiety, and stress symptoms in the population, and will also help to identify risk factors of psychological distress within this population.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak
Actual Study Start Date : June 22, 2020
Estimated Primary Completion Date : September 30, 2020
Estimated Study Completion Date : December 31, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mental Health

Primary Outcome Measures :
  1. DASS-21 Scores [ Time Frame: single measurement upon study enrolment ]
    Depression, Anxiety and Stress Scale (DASS-21) is a validated 21-item measure that has been widely used during the current crisis.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Migrant workers who have or have not been diagnosed with COVID-19.

Inclusion Criteria:

  • 21 years, living in a dorm or EXPO/NUS Prince George Residences

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04448704

Layout table for location contacts
Contact: Jean Liu, PhD +65 9223 6008
Contact: Edina Tan

Layout table for location information
EXPO Recruiting
Singapore, Singapore
Sponsors and Collaborators
Yale-NUS College
Layout table for additonal information
Responsible Party: Yale-NUS College Identifier: NCT04448704    
Other Study ID Numbers: CCF@EXPO/R001/2020
First Posted: June 26, 2020    Key Record Dates
Last Update Posted: June 30, 2020
Last Verified: June 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No